Valuation Zydus Lifesciences Limited

Equities

Market Closed - NSE India S.E. Other stock markets 07:05:10 2026-05-15 am EDT			5-day change	1st Jan Change
1,011.70 ^INR	+2.02%		+7.62%	+10.65%

May. 13	Zydus Lifesciences to buy Assertio for $166.4 million	RE
May. 13	Zydus to Acquire Assertio for $166.4 Million	DJ

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	451,368	356,774	497,549	1,013,630	891,926	1,018,007	-	-
Change	-	-20.96%	39.46%	103.72%	-12.01%	14.14%	-	-
Enterprise Value (EV) ¹	474,956	387,665	503,450	1,010,265	894,053	1,011,682	966,488	985,024
Change	-	-18.38%	29.87%	100.67%	-11.5%	13.16%	-4.47%	1.92%
P/E ratio	21.2x	7.95x	25.5x	26.4x	19.7x	22.2x	24.6x	21.7x
PBR	3.47x	2.1x	2.84x	5.11x	3.72x	3.65x	3.24x	2.88x
PEG	-	0x	-0.5x	0.3x	1.1x	15.87x	-2.49x	1.6x
Capitalization / Revenue	2.99x	2.34x	2.89x	5.19x	3.84x	3.9x	3.58x	3.32x
EV / Revenue	3.14x	2.54x	2.92x	5.17x	3.85x	3.87x	3.4x	3.21x
EV / EBITDA	14.2x	11.6x	14.1x	19x	13.4x	14.4x	14.3x	13.3x
EV / EBIT	18.2x	14.8x	16x	22.3x	15.5x	17.5x	17.8x	16.6x
EV / FCF	19.5x	43x	30.4x	43.5x	17.7x	33.6x	26.8x	24.6x
FCF Yield	5.14%	2.33%	3.29%	2.3%	5.66%	2.98%	3.73%	4.06%
Dividend per Share ²	3.5	2.5	6	3	11	8.111	7.57	7.604
Rate of return	0.79%	0.72%	1.22%	0.3%	1.24%	0.8%	0.75%	0.75%
EPS ²	20.84	43.83	19.3	38.14	44.97	45.6	41.09	46.53
Distribution rate	16.8%	5.7%	31.1%	7.87%	24.5%	17.8%	18.4%	16.3%
Net sales ¹	151,022	152,652	172,374	195,474	232,415	261,273	283,994	306,975
EBITDA ¹	33,410	33,407	35,755	53,033	66,755	70,161	67,793	74,056
EBIT ¹	26,162	26,277	31,372	45,392	57,597	57,743	54,237	59,236
Net income ¹	21,336	44,873	19,603	38,595	45,255	46,584	41,497	47,072
Net Debt ¹	23,588	30,891	5,901	-3,365	2,127	-6,324	-51,519	-32,983
Reference price ²	440.90	348.50	491.55	1,007.35	886.40	1,011.70	1,011.70	1,011.70
Nbr of stocks (in thousands)	1,023,743	1,023,743	1,012,204	1,006,234	1,006,234	1,006,234	-	-
Announcement Date	5/27/21	5/20/22	5/18/23	5/17/24	5/20/25	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ZYDUS LIFESCIENCES LIMITED	22.19x	3.87x	14.42x	0.8%	10.61B
SUN PHARMACEUTICAL INDUSTRIES LTD.	38.88x	7.36x	25.14x	0.8%	46.97B
OTSUKA HOLDINGS CO., LTD.	19.21x	2.11x	10.09x	1.3%	37.28B
CIPLA LIMITED	27.75x	3.75x	17.7x	0.94%	12.06B
KRKA, D. D.	19.53x	3.38x	12.51x	3.49%	9.09B
ONO PHARMACEUTICAL CO., LTD.	16.71x	2.21x	8.37x	3.21%	7.5B
GEDEON RICHTER	8.72x	2.07x	5.43x	5.29%	7.39B
GLENMARK PHARMACEUTICALS LIMITED	36.28x	4x	16.64x	0.23%	6.84B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	49.65x	-	-	-	5.77B
Average	26.55x	3.59x	13.79x	2.01%	15.95B
Weighted average by Cap.	27.97x	4.36x	16.36x	1.47%